Tonix Files for Patent for TNX-1500 to Treat Autoimmune Diseases

Tonix Files for Patent for TNX-1500 to Treat Autoimmune Diseases

283246

Tonix Files for Patent for TNX-1500 to Treat Autoimmune Diseases

Tonix Pharmaceuticals has filed a patent application with the World Intellectual Property Organization covering the use of TNX-1500 — its third-generation anti-CD154 antibody — for the prevention and treatment of autoimmune diseases, such as multiple sclerosis (MS), and organ transplant rejection. “There remains a significant need for new treatments with improved activity and tolerability to prevent or treat organ transplant rejection and to treat autoimmune conditions, including systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis,” Seth Lederman,…

You must be logged in to read/download the full post.